Bennett Lawrence Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q2 | – | Sell |
-58,021
| Closed | -$15.4M | – | 93 |
|
|
2014
Q1 | $15.4M | Buy |
58,021
+21,305
| +58% | +$5.65M | 2.28% | 14 |
|
|
2013
Q4 | $13.3M | Buy |
36,716
+35,804
| +3,926% | +$13M | 2.05% | 15 |
|
|
2013
Q3 | $485K | Sell |
912
-2,309
| -72% | -$1.23M | 0.08% | 72 |
|
|
2013
Q2 | $754K | Buy |
+3,221
| New | +$754K | 0.14% | 78 |
|